TotalMarketCap

Vir Biotechnology

VIRNasdaq United StatesHealth CareBiotechnology: Biological Products (No Diagnostic Substances)

Market cap

$1.889 B

$11.03 -6.29%

Close of 6 Nov 2026

As of 6 Nov 2026, Vir Biotechnology (VIR) has a market capitalization of $1.89B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$68.6M

#2611 by revenue

Earnings

-$438.0M

Loss-making

Shares outstanding

171,270,773

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →
  1. #34Biocryst PharmaceuticalsBCRX$1.95B
  2. #35Replimune GroupREPL$1.90B
  3. #36Vir BiotechnologyVIR$1.89B
  4. #37MesoblastMESO$1.83B
  5. #38Maze TherapeuticsMAZE$1.80B

What if Vir Biotechnology were worth as much as…

Open the what-if tool →

Gold $28.2T

$164,866.86

Per share 14,947× higher

Bitcoin $1.53T

$8,920.66

Per share 809× higher

Apple $5.02T

$29,285.69

Per share 2,655× higher

Or at a round number

$5.00B$10.0B$20.0B$50.0B

Where these numbers come from

Share counts and financials for Vir Biotechnology are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.